Vitrolife Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Bronwyn Brophy O´Connor
Chief executive officer
SEK 16.9m
Total compensation
| CEO salary percentage | 59.52% |
| CEO tenure | 2.9yrs |
| CEO ownership | n/a |
| Management average tenure | 2.5yrs |
| Board average tenure | 6.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | -SEK 5b |
| Dec 31 2025 | SEK 17m | SEK 10m | -SEK 5b |
| Sep 30 2025 | n/a | n/a | SEK 440m |
| Jun 30 2025 | n/a | n/a | SEK 455m |
| Mar 31 2025 | n/a | n/a | SEK 498m |
| Dec 31 2024 | SEK 17m | SEK 10m | SEK 513m |
| Sep 30 2024 | n/a | n/a | -SEK 4b |
| Jun 30 2024 | n/a | n/a | -SEK 4b |
| Mar 31 2024 | n/a | n/a | -SEK 4b |
| Dec 31 2023 | SEK 7m | SEK 6m | -SEK 4b |
Compensation vs Market: Bronwyn's total compensation ($USD1.75M) is below average for companies of similar size in the US market ($USD5.14M).
Compensation vs Earnings: Bronwyn's compensation has been consistent with company performance over the past year.
CEO
Bronwyn Brophy O´Connor (52 yo)
Ms. Bronwyn Brophy O´Connor is Member of Executive Board of Carl Zeiss AG from May 2026. She serves as CEO of Carl Zeiss Meditec AG. Ms. O´Connor is CEO & President of Vitrolife AB (publ) from August 01, 2...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & President | 2.9yrs | SEK 16.86m | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Chief Operations Officer | less than a year | no data | no data | |
| Senior Vice President of Technologies | no data | no data | no data | |
| Senior Vice President of Sales & Marketing | 2.5yrs | no data | no data | |
| Vice President Strategy | no data | no data | no data | |
| Senior VP & GM of China | no data | no data | no data | |
| Senior Vice President Innovation | 2.5yrs | no data | no data | |
| Senior Vice President Genetic Services | 4.5yrs | no data | no data | |
| Senior VP & GM of North America | no data | no data | no data |
Experienced Management: VTRL.Y's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Director | 7.2yrs | SEK 561.00k | 0.0081% $ 103.8k | |
| Chairman of the Board | 11.5yrs | SEK 1.35m | 0.022% $ 287.0k | |
| Director | less than a year | no data | no data | |
| Independent Director | 13.3yrs | SEK 590.00k | 0.0037% $ 47.2k | |
| Director | less than a year | no data | no data | |
| Independent Director | 6.1yrs | SEK 533.00k | no data |
Experienced Board: VTRL.Y's board of directors are considered experienced (6.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/06 19:59 |
| End of Day Share Price | 2026/07/02 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Vitrolife AB (publ) is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Kallum Titchmarsh | BofA Global Research |
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |